| 000 | 02225cam a2200277zu 4500 | ||
|---|---|---|---|
| 001 | 88836453 | ||
| 003 | FRCYB88836453 | ||
| 005 | 20250107104150.0 | ||
| 006 | m o d | ||
| 007 | cr un | ||
| 008 | 250107s2016 fr | o|||||0|0|||eng d | ||
| 020 | _a9780128023020 | ||
| 035 | _aFRCYB88836453 | ||
| 040 |
_aFR-PaCSA _ben _c _erda |
||
| 100 | 1 | _aModjarrad, Kayvon | |
| 245 | 0 | 1 |
_aHuman Vaccines _bEmerging Technologies in Design and Development _c['Modjarrad, Kayvon'] |
| 264 | 1 |
_bElsevier Science _c2016 |
|
| 300 | _a p. | ||
| 336 |
_btxt _2rdacontent |
||
| 337 |
_bc _2rdamdedia |
||
| 338 |
_bc _2rdacarrier |
||
| 650 | 0 | _a | |
| 700 | 0 | _aModjarrad, Kayvon | |
| 856 | 4 | 0 |
_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88836453 _qtext/html _a |
| 520 | _aHuman Vaccines: Emerging Technologies in Design and Development discusses the advances in molecular biology, biophysics, and informatics?among other disciplines?that have provided scientists with the tools to create new vaccines against emerging and re-emerging pathogens. For example, the virus-like particle technologies that led to licensing of highly efficacious HPV vaccines have only come into full realization in the last 10 years. Their success has, in turn, accelerated the pace with which nanoparticle vaccines are being developed Given the rapidity with which the field is changing and the absence of any text documenting this change, there is a need for a resource that surveys these new vaccine technologies, assesses their potential, and describes their applications. This book provides that resource and complements traditional vaccinology books, but also serves as an excellent standalone for researchers and students with basic knowledge in immunology. Introduces new topics in vaccine immunology in the context vaccine design and production Consolidates the growing body of knowledge on new vaccine technologies that have only emerged in the past 2 ? 3 decades Reviews the currently licensed vaccines that have utilized leading-edge technologies and how this has translated into improved efficacy and safety Provides a broad overview of innovative vaccine technologies, including immunological aspects | ||
| 999 |
_c14841 _d14841 |
||